In vitro studies indicate that p42/p44(MAPK) phosphorylate both nuclea
r and cytoplasmic proteins. However, the functional targets of p42/p44
(MAPK) activation in vivo remain unclear. To address this question, we
localized activated p42/p44(MAPK) in hippocampus and cortex and deter
mined their signaling effects after electroconvulsive shock treatment
(ECT) in rats. Phosphorylated p42/p44(MAPK) content increased in the c
ytoplasm of hippocampal neurons in response to ECT. Consistent with th
is cytoplasmic localization, inhibition of ECT-induced p42/p44(MAPK) a
ctivation by the extracellular signal-regulated kinase kinase inhibito
r PD098059 blocked phosphorylation of the cytoplasmic protein microtub
ule-associated protein 2c (MAP2c), but failed to inhibit the induction
of the nuclear protein c-Fos in response to ECT. In contrast to hippo
campal neurons, cortical neurons exhibited an increase in amount of ph
osphorylated p42/p44(MAPK) in both the nucleus and cytoplasm after ECT
. Accordingly, PD098059 blocked the induction of Fos-like immunoreacti
vity in the nuclei of cortical neurons as well as MAP2c phosphorylatio
n in the cytoplasm. Our data indicate that both nuclear and cytoplasmi
c substrates can be activated by p42/p44(MAPK) in vivo. However, the f
unctional targets of p42/p44(MAPK) signaling depend on the precise loc
ation of p42/p44(MAPK) within different subcellular compartments of br
ain regions, These results indicate unique functional pathways of p42/
p44(MAPK)-mediated signal transduction within different brain regions
in vivo.